LMTK2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.031400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.824100E-02
Normal-vs-Stage2
2.965400E-01
Normal-vs-Stage3
9.940800E-01
Normal-vs-Stage4
5.028300E-02
Stage1-vs-Stage2
6.445000E-01
Stage1-vs-Stage3
6.314400E-02
Stage1-vs-Stage4
3.948400E-01
Stage2-vs-Stage3
2.270200E-01
Stage2-vs-Stage4
2.858600E-01
Stage3-vs-Stage4
4.347600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.179800E-01
Normal-vs-AfricanAmerican
1.647970E-01
Normal-vs-Asian
3.896400E-01
Caucasian-vs-AfricanAmerican
5.354000E-01
Caucasian-vs-Asian
8.707800E-01
AfricanAmerican-vs-Asian
5.296800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.685800E-01
Normal-vs-Female
3.389800E-01
Male-vs-Female
7.509600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.137020E-01
Normal-vs-Age(41-60Yrs)
1.994590E-01
Normal-vs-Age(61-80Yrs)
3.232200E-01
Normal-vs-Age(81-100Yrs)
7.412400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.997600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.520600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.609430E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.402600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.455460E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.779380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.403200E-01
Normal-vs-Daily Drinker
4.633000E-01
Normal-vs-Weekly Drinker
4.598200E-01
Normal-vs-Occasional Drinker
2.848800E-01
Normal-vs-Social Drinker
1.819250E-01
Non Drinker-vs-Daily Drinker
5.738000E-01
Non Drinker-vs-Weekly Drinker
9.968000E-01
Non Drinker-vs-Occasional Drinker
2.055200E-01
Non Drinker-vs-Social Drinker
9.783600E-02
Daily Drinker-vs-Weekly Drinker
6.707800E-01
Daily Drinker-vs-Occasional Drinker
1.187200E-01
Daily Drinker-vs-Social Drinker
5.236100E-02
Weekly Drinker-vs-Occasional Drinker
2.961600E-01
Weekly Drinker-vs-Social Drinker
2.251600E-01
Occasional Drinker-vs-Social Drinker
9.693600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.343000E-01
Normal-vs-Grade 2
2.563700E-02
Normal-vs-Grade 3
6.319700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.118600E-01
Grade 1-vs-Grade 3
2.117600E-01
Grade 1-vs-Grade 4
1.343000E-01
Grade 2-vs-Grade 3
5.732100E-02
Grade 2-vs-Grade 4
2.563700E-02
Grade 3-vs-Grade 4
6.319700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.125400E-01
Normal-vs-NonDiabetic
3.223800E-01
Diabetic-vs-NonDiabetic
1.646420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.624800E-01
Normal-vs-NoPancreatitis
3.465000E-01
Pancreatitis-vs-NoPancreatitis
4.464800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.302400E-01
Normal-vs-N1
3.121000E-01
N0-vs-N1
8.186000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.987180E-01
Normal-vs-TP53-NonMutant
1.812150E-01
TP53-Mutant-vs-TP53-NonMutant
7.065800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
